← Back to Search

eHealth Cancer Genetic Counseling for Cancer (eReach Trial)

N/A
Recruiting
Research Sponsored by Abramson Cancer Center at Penn Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
A personal history of one or more of the following: metastatic breast cancer, advanced ovarian cancer (Stage III-IV), metastatic pancreatic cancer, metastatic prostate cancer, Naive to previous cancer germline genetic testing
Must not have
Uncontrolled psychiatric/mental condition or severe physical, neurological or cognitive deficits rendering individual unable to understand study goals and tasks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline - within 7 days of visit 2
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare web-based eHealth cancer counseling to the standard of care to see if it is equally or more effective.

Who is the study for?
This trial is for adults who speak English and have certain advanced cancers (metastatic breast, ovarian stages III-IV, pancreatic, or prostate cancer) and haven't had genetic testing for cancer before. It's not suitable for those with hearing/vision/speech issues or uncontrolled mental conditions that affect understanding of the study.
What is being tested?
The study tests if web-based eHealth delivery of genetic counseling before and after testing can match or surpass standard in-person care in terms of patients' knowledge and emotional well-being.
What are the potential side effects?
Since this trial involves educational interventions rather than medications, traditional side effects are not expected. However, participants may experience a range of emotions as they learn about their genetic risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have had advanced cancer (breast, ovarian, pancreatic, prostate) and haven't had genetic testing for it.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any mental or severe physical conditions that prevent me from understanding this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline - within 7 days of visit 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline - within 7 days of visit 2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Anxiety
Change in Knowledge
Secondary study objectives
Change in Cancer Specific Distress
Change in Depression
Change in Health Behaviors
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: ARM DExperimental Treatment2 Interventions
Visit 1/Pre-Test Session - Self-directed web-based eHealth pre-test session intervention. Visit 2/Disclosure Session - Self-directed web-based eHealth result disclosure intervention.
Group II: ARM CExperimental Treatment2 Interventions
Visit 1/Pre-Test Session - Self-directed web-based eHealth pre-test session intervention. Visit 2/Disclosure Session - Standard-of-Care Post-Test Counseling with a genetic counselor either in-person or by remote services (Telephone or Video Conferencing).
Group III: ARM BExperimental Treatment2 Interventions
Visit 1/Pre-Test Session - Standard-of-Care Pre-Test Counseling with a genetic counselor either in-person or by remote services (Telephone or Video Conferencing). Visit 2/Disclosure Session - Self-directed web-based eHealth result disclosure intervention.
Group IV: ARM AExperimental Treatment1 Intervention
Visit 1/Pre-Test Session - Standard-of-Care Pre-Test Counseling with a genetic counselor either in-person or by remote services (Telephone or Video Conferencing). Visit 2/Disclosure Session - Standard-of-Care Post-Test Counseling with a genetic counselor either in-person or by remote services (Telephone or Video Conferencing).

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor
418 Previous Clinical Trials
463,562 Total Patients Enrolled
Basser Center for BRCAUNKNOWN
1 Previous Clinical Trials
61 Total Patients Enrolled
Fox Chase Cancer CenterOTHER
234 Previous Clinical Trials
38,813 Total Patients Enrolled
Merck Sharp & Dohme LLCIndustry Sponsor
4,031 Previous Clinical Trials
5,189,144 Total Patients Enrolled
AstraZenecaIndustry Sponsor
4,425 Previous Clinical Trials
289,140,384 Total Patients Enrolled
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
107,795 Total Patients Enrolled

Media Library

Pre-Test Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04353973 — N/A
Cancer Research Study Groups: ARM B, ARM C, ARM A, ARM D
Cancer Clinical Trial 2023: Pre-Test Intervention Highlights & Side Effects. Trial Name: NCT04353973 — N/A
Pre-Test Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04353973 — N/A
~0 spots leftby Dec 2024